![](/img/cover-not-exists.png)
Final results of depatuxizumab mafodotin plus temozolomide in recurrent glioblastoma patients: Real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO)
Padovan, M., Eoli, M., Pellerino, A., Rizzato, S., Caserta, C., Simonelli, M., Michiara, M., Caccese, M., Anghileri, E., Finocchiaro, G., Zagonel, V., Rudà , R., Lombardi, G.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.478
Date:
September, 2020
File:
PDF, 102 KB
2020